Biotricity, Inc. - Condensed Consolidated Balance Sheets - USD ($)		Sep. 30, 2017	Mar. 31, 2017
CURRENT ASSETS
Cash		$ 607,149	$ 424,868
Harmonized sales tax recoverable		20,541	939
Deposits and other receivables		6,722	14,705
Total Current Assets		634,412	440,512
Deposits and other receivables		33,000	33,000
Total Assets		667,412	473,512
Current Liabilities:
Accounts payable and accrued liabilities	[1]	762,804	1,137,454
Convertible promissory note	[2]		1,556,990
Derivative liabilities	[3]		2,163,884
TOTAL LIABILITIES		762,804	4,858,328
Stockholders' Deficiency
Preferred stock	[4]	1	1
Common stock	[5]	30,731	27,199
Shares to be issued	[6]	13,625
Additional paid-in capital		22,025,886	14,308,583
Accumulated other comprehensive loss		(583,732)	(413,384)
Accumulated deficit		(21,581,903)	(18,307,215)
TOTAL STOCKHOLDERS' DEFICIENCY		(95,392)	(4,384,816)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY		667,412	473,512
Commitments	[7]
Subsequent Events	[8]

[1] See Note 4

[2] See Note 5

[3] See Note 6

[4] $0.001 par value; 10,000,000 shares authorized as at September 30, 2017 and March 31, 2017, respectively, 1 share issued and outstanding as at September 30, 2017 and March 31, 2017, respectively. [Note 7]

[5] $0.001 par value; 125,000,000 authorized as at September 30, 2017 and March 31, 2017, respectively. Issued and outstanding common shares: 21,607,634 as at September 30, 2017 and 18,075,848 as at March 31, 2017, respectively, and exchangeable shares of 9,123,031 outstanding as at September 30, 2017 and March 31, 2017, respectively. [Note 7]

[6] See Note 7

[7] See Note 9

[8] See Note 10